A process evaluation of Ontario, Canada’s 2023–24 older-adult RSV vaccination program

A process evaluation of Ontario, Canada’s 2023–24 older-adult RSV vaccination program

Respiratory syncytial virus (RSV) is a major cause of respiratory illness in older adults. During the 2023–2024 respiratory season, Ontario was the first and only province in Canada to launch a publicly funded RSV vaccination program for older adults. A process evaluation of the program was complete...

Full description

Saved in:
Bibliographic Details
Main Authors: Reed Morrison, Janice Sarmiento, Jamie Park, Gillian Lim, Christina Renda, Michael Whelan, Allison McGeer, Tara Harris, Sarah E. Wilson
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Immunization
immunization program
respiratory syncytial virus
RSV
evaluation
long term care
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2550089
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2025.2550089

Similar Items